Validation of Bone Conversion in Osteoconductive and Osteoinductive Bone Substitutes
Tóm tắt
Bone reconstruction can be performed with an autogeneic graft from various donor regions. Osteoconductive and osteoinductive bone substitutes originate from substances of diverse chemical and morphological types and can have a synthetic or a biological derivation. Alongside autogeneic bone transplants and allogenic and xenogeneic bone implants, alloplastic bone replacements of synthetic or semi-synthetic origin are being used for defect reconstruction. In an animal model in rabbits five bone substitutes and one autogeneic graft were surgically incorporated into identical bone defects (10times 10 mm in size) in six anatomically defined regions of the skull. With scintigraphic and histological methods, the metabolic dynamics of the bone is examined as it reacts to the transplantation of autogeneic bone or to implanted bone replacement material. The different autogeneic, xenogeneic and alloplastic bone replacement materials can be differentiated according to the functional quality of the new tissue and the dynamics of the bone conversion thus induced. In the comparison of mineralized, osteoconductive bone subsitutes (TCP, HA, calcium carbonate ceramics) with demineralized, osteoinductive implants (DBM new, DBM old) and autogeneic bone grafts, the bone inducing matrices show the largest quantity of new bone formation, making possible a volume-constant reconstruction.
Tài liệu tham khảo
Dambe LT,Saur K andSchweiberer L (1978) The revascularisation of fresh homologous bone grafts in the diaphysis of long bones in dogs. Arch Orthop Trauma Surg 11: 35
Dingeldein E,Donath K,Wahlig H andBauer HJ (1994) Einheilung einer porösen Hydroxylapatit-Keramik biologischer Herkunft im spongiösen Knochenlager von Kaninchen. Osteosynthese International 2: 112
Heide H (1996) Cerasorb® als ;2-Tricalciumphosphat zur Behandlung von Knochendefekten. Persönliche Mitteilung Dr. H. Heide
Heide H,Erhard H,Klimmek A,Köster-Lösche K,Krieger W andKubicek J (1979) Bioaktive Endo-prothesenoberfl¨achen, Teil 2: Erste tiermedizinische und klinische Erfahrungen mit CaP-Keramik. Bericht Bundesministerium f¨ur Forschung und Technologie. Bonn, AZ: 01 VG 146-AK/NT/MT-267
Patel A,Honnart F,Guillemin G andPatat JL (1980) Use of Madrepore skeletal fragments in orthopaedic and reconstructive surgery. Calcif Tissue Int 31: 108
Peelen JG,Rejda BV,Vermeiden JP and de Groot K (1977) Sintered tricalciumphosphate as bioceramic. Ceramics 9: 226
Rueger JM (1992) Knochenersatzmittel. Hefte Unfallheilkunde 213: 35
Sampath TK andReddi AH (1984) Distribution of bone inductive proteins in mineralized and demineralized extracellular matrix. Biochem Biophys Res Com 119: 949
Schmitz JP andHollinger JO (1986) The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop 205: 299
Schnettler R,Dingeldein E andHerr G (1998) Defect reconstruction using demineralized bone matrix. Experimental studies. Orthopäde 27: 80
Uchida A,Nade S,McCartney E andChing W 1985) Bone ingrowth into three different porous ceramics implanted into the tibia of rats and rabbits. J Orthop Res 3: 65
Urist MR,Iwata I,Ceccotti PL et al. (1973) Bone Morphogenesis in Implants of Insoluble Bone Gelatin: cell differentiation/ osteogenesis/noncollagenous proteins. Proc Nat Acad Sci USA 70: 3511
Wippermann BW (1996) Hydroxylapatitkeramik als Knochenersatzstoff-Experimentelle Untersuchungen am Segmentdefekt der Schafttibia. Hefte zu Der Unfallchirurg 260: 13